{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T08:49:39Z","timestamp":1700297379022},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2000,8,31]],"date-time":"2000-08-31T00:00:00Z","timestamp":967680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,8,31]],"date-time":"2000-08-31T00:00:00Z","timestamp":967680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2000,9,1]]},"DOI":"10.1038\/sj.leu.2401870","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T18:37:20Z","timestamp":1031164640000},"page":"1661-1666","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Autoantibodies to Abl and Bcr proteins"],"prefix":"10.1038","volume":"14","author":[{"given":"M","family":"Talpaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JE","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Kantarjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Kurzrock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,8,31]]},"reference":[{"key":"BF2401870_CR1","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/0092-8674(84)90438-0","volume":"37","author":"JB Konopka","year":"1984","unstructured":"Konopka JB, Watanabe SM, Witte ON . An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity Cell 1984 37: 1035\u20131042","journal-title":"Cell"},{"key":"BF2401870_CR2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/0042-6822(85)90361-7","volume":"140","author":"W Kloetzer","year":"1985","unstructured":"Kloetzer W, Kurzrock R, Smith L, Talpaz M, Spiller M, Gutterman J, Arlinghaus R . The human cellular abl gene product in the chronic myelogenous leukemia cell line K562 has an associated tyrosine kinase activity Virology 1985 140: 230\u2013238","journal-title":"Virology"},{"key":"BF2401870_CR3","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/315550a0","volume":"315","author":"E Shtivelman","year":"1985","unstructured":"Shtivelman E, Lifshitz B, Gale RP, Canaani E . Fused transcript of ABL and BCR genes in chronic myelogenous leukaemia Nature (Lond) 1985 315: 550\u2013554","journal-title":"Nature (Lond)"},{"key":"BF2401870_CR4","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1056\/NEJM198810133191506","volume":"319","author":"R Kurzrock","year":"1988","unstructured":"Kurzrock R, Gutterman JU, Talpaz M . The molecular genetics of Philadelphia chromosome positive leukemias New Engl J Med 1988 319: 990\u2013997","journal-title":"New Engl J Med"},{"key":"BF2401870_CR5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/325631a0","volume":"325","author":"R Kurzrock","year":"1987","unstructured":"Kurzrock R, Shtalrid M, Romero P, Kloetzer WS, Talpaz M, Trujillo JM, Blick M, Beran M, Gutterman JU . A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leuaemia Nature 1987 325: 631\u2013635","journal-title":"Nature"},{"key":"BF2401870_CR6","first-page":"305","volume":"9","author":"A Barrett","year":"1992","unstructured":"Barrett A, Jiang YZ . Immune responses to chronic myeloid leukaemia Bone Marrow Transplant 1992 9: 305\u2013311","journal-title":"Bone Marrow Transplant"},{"key":"BF2401870_CR7","first-page":"253","volume":"8","author":"YZ Jiang","year":"1991","unstructured":"Jiang YZ, Kanfer EJ, Macdonald D, Cullis JO, Goldman JM, Barrett AJ . Graft-versus-leukemia following allogeneic bone marrow transplantation: emergence of cytotoxic T lymphocytes reacting to host leukaemia cells Bone Marrow Transplant 1991 8: 253\u2013258","journal-title":"Bone Marrow Transplant"},{"key":"BF2401870_CR8","first-page":"1344","volume":"9","author":"GJA Ten Bosch","year":"1995","unstructured":"Ten Bosch GJA, Toornvliet AC, Friede T, Melief CJM, Leeksma OC . Recognition of peptides corresponding to the joining region of p210BCR-ABL protein by human T cells Leukemia 1995 9: 1344\u20131348","journal-title":"Leukemia"},{"key":"BF2401870_CR9","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1182\/blood.V88.6.2118.bloodjournal8862118","volume":"87","author":"G Pawelec","year":"1996","unstructured":"Pawelec G, Max H, Halder T, Bruserud O, Merl A, Silva PD, Kalbacher H . BCR\/ABL leukemia oncogene fusion peptides selectively bind to certain HLA-DR alleles and can be recognized by T cells found at low frequency in the repertoire of normal donors Blood 1996 87: 2118\u20132124","journal-title":"Blood"},{"key":"BF2401870_CR10","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1182\/blood.V87.9.3587.bloodjournal8793587","volume":"87","author":"M Bocchia","year":"1996","unstructured":"Bocchia M, Korontsvit T, Xu Q, Mackinnon S, Yang SY, Sette A, Scheinberg DA . Specific human cellular immunity to bcr-abl oncogene-derived peptides Blood 1996 87: 3587\u20133592","journal-title":"Blood"},{"key":"BF2401870_CR11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s002620050270","volume":"42","author":"G Pawelec","year":"1996","unstructured":"Pawelec G, Rehbein A, Schlotz E . Cellular immune responses to autologous chronic myelogenous leukemia cells in vitro Cancer Immunol Immunother 1996 42: 193\u2013199","journal-title":"Cancer Immunol Immunother"},{"key":"BF2401870_CR12","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3109\/10428199509059647","volume":"18","author":"G Pawelec","year":"1995","unstructured":"Pawelec G, Silva PD, Max H, Kalbacher H, Schmidt H, Bruserud O, Zugel U, Baier W, Rehbein A, Pohla H . Relative roles of natural killer- and T cell-mediated anti-leukemia effects in chronic myelogenous leukemia patients treated with interferon-\u03b1 Leuk Lymphoma 1995 18: 471\u2013478","journal-title":"Leuk Lymphoma"},{"key":"BF2401870_CR13","first-page":"63","volume":"29","author":"G Pawelec","year":"1989","unstructured":"Pawelec G, Schneider E, Ehninger G, Rehbein A, Schmidt H . Partial correction of defective generation of lymphokine-activated killer cells in patients with chronic myelogenous leukemia after in vitro treatment with interferon-\u03b1 (Wellferon) Cancer Immunol Immunother 1989 29: 63\u201366","journal-title":"Cancer Immunol Immunother"},{"key":"BF2401870_CR14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1182\/blood.V45.3.321.321","volume":"45","author":"CB Lozzio","year":"1975","unstructured":"Lozzio CB, Lozzio BB . Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome Blood 1975 45: 321\u2013334","journal-title":"Blood"},{"key":"BF2401870_CR15","first-page":"2100","volume":"9","author":"BS Andersson","year":"1995","unstructured":"Andersson BS, Collins VP, Kurzrock R, Childs C, Ost A, Cork A, Trujillo JM, Beran M, Freireich EJ, Siciliano M, Deisseroth AB . KBM-7, a human myeloid leukemia cell line with double Philadelphia chronosomes lacking normal c-ABL and BCR transcripts Leukemia 1995 9: 2100\u20132108","journal-title":"Leukemia"},{"key":"BF2401870_CR16","first-page":"447","volume":"70","author":"L Pegoraro","year":"1983","unstructured":"Pegoraro L, Matera L, Ritz J, Levis A, Palumbo A, Biagini G . Establishment of a Ph1-positive human cell line (BV173) J Natl Cancer Inst 1983 70: 447\u2013451","journal-title":"J Natl Cancer Inst"},{"key":"BF2401870_CR17","first-page":"231","volume":"132","author":"S Avrameas","year":"1981","unstructured":"Avrameas S, Guilbert B, Dighiero G . Natural antibodies against tubulin, actin, myoglobin, thyroglobulin, fetuin, albumin, and transferrin are present in normal human sera and monoclonal immunoglobuins from multiple myeloma and Waldenstrom\u2019s macroglobulinemia may express similar antibody specificities Ann Immunol 1981 132: 231\u2013236","journal-title":"Ann Immunol"},{"key":"BF2401870_CR18","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/BF01546322","volume":"14","author":"G Sigounas","year":"1994","unstructured":"Sigounas G, Kolaitis N, Monell-Torrens E, Notkins AL . Polyreactive IgM antibodies in the circulation are masked by anitgen binding J Clin Immunol 1994 14: 375\u2013381","journal-title":"J Clin Immunol"},{"key":"BF2401870_CR19","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.4049\/jimmunol.128.6.2779","volume":"128","author":"B Guilbert","year":"1982","unstructured":"Guilbert B, Dighiero G, Avrameas S . Naturally occurring autoantibodies against nine common antigens in human sera. Detection, isolation and characterization J Immunol 1982 128: 2779\u20132785","journal-title":"J Immunol"},{"key":"BF2401870_CR20","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3233\/HAB-1997-8204","volume":"8","author":"J George","year":"1997","unstructured":"George J, Gilburd B, Schoenfeld Y . The emerging concept of pathogenic natural autoantibodies Hum Antibodies 1997 8: 70\u201375","journal-title":"Hum Antibodies"},{"key":"BF2401870_CR21","first-page":"16","volume":"54","author":"ML Disis","year":"1994","unstructured":"Disis ML, Calenoff E, McLaughlin G, Murphy AE, Chen W, Groner B, Jeschke M, Lydon N, McGlynn E, Livingston, RB, Moe R, Cheever MA . Existent T-cell and antibody immunity to HER-2\/neu protein in patients with breast cancer Cancer Res 1994 54: 16\u201320","journal-title":"Cancer Res"},{"key":"BF2401870_CR22","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1200\/JCO.1997.15.11.3363","volume":"15","author":"ML Disis","year":"1997","unstructured":"Disis ML, Pupa SM, Gralow JR, Dittadi R, Menard S, Cheever MA . High-titer HER-2\/neu protein-specific antibody can be detected in patients with early-stage breast cancer J Clin Oncol 1997 15: 3363\u20133367","journal-title":"J Clin Oncol"},{"key":"BF2401870_CR23","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1073\/pnas.89.8.3439","volume":"89","author":"AM Davidoff","year":"1992","unstructured":"Davidoff AM, Iglehart J, Marks JR . Immune response to p53 is dependent upon p53\/HSP70 complexes in breast cancers Proc Natl Acad Sci USA 1992 89: 3439\u20133442","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2401870_CR24","first-page":"6380","volume":"52","author":"B Schlichtholz","year":"1992","unstructured":"Schlichtholz B, Legros Y, Gillet D, Gaillard C, Marty M, Lane D, Calvo F, Soussi T . The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot Cancer Res 1992 52: 6380\u20136384","journal-title":"Cancer Res"},{"key":"BF2401870_CR25","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ijc.2910300404","volume":"30","author":"LV Crawford","year":"1982","unstructured":"Crawford LV, Pim DC, Bulbrook RD . Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer Int J Cancer 1982 30: 403\u2013408","journal-title":"Int J Cancer"},{"key":"BF2401870_CR26","first-page":"329","volume":"37","author":"K Ben-Mahrez","year":"1988","unstructured":"Ben-Mahrez K, Thierry D, Sorokine I, Danna-Muller A, Kohiyama M . Detection of circulating antibodies against c-myc protein in cancer patient sera Br J Cancer 1988 37: 329\u2013334","journal-title":"Br J Cancer"},{"key":"BF2401870_CR27","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/ijc.2910470506","volume":"47","author":"I Sorokine","year":"1991","unstructured":"Sorokine I . Presence of circulating anti-c-myb oncogene product antibodies in human sera Int J Cancer 1991 47: 665\u2013669","journal-title":"Int J Cancer"},{"key":"BF2401870_CR28","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/ijc.2910390211","volume":"39","author":"C Caron de Frometal","year":"1987","unstructured":"Caron de Frometal C, May-levin F, Mouriesse H, Lemerle J, Chandrasekaran K, May P . Presence of circulating antibodies against cellular protein p53 in a notable proportion of children with B-cell lylmphoma Int J Cancer 1987 39: 185\u2013189","journal-title":"Int J Cancer"},{"key":"BF2401870_CR29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3109\/03009749609080000","volume":"25","author":"JR Carpetis","year":"1996","unstructured":"Carpetis JR, Currie BJ, Good MF . Towards understanding the pathogenesis of rheumatic fever Scand J Rheumatol 1996 25: 127\u2013131","journal-title":"Scand J Rheumatol"},{"key":"BF2401870_CR30","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/icb.1997.16","volume":"75","author":"JM Davies","year":"1997","unstructured":"Davies JM . Molecular mimicry: can epitope mimicry induce autoimmune disease? Immunol Cell Biol 1997 75: 113\u2013126","journal-title":"Immunol Cell Biol"},{"key":"BF2401870_CR31","first-page":"S27","volume":"12","author":"EM Tan","year":"1994","unstructured":"Tan EM, Muro Y, Pollar KM . Autoantibody-defined epitopes on nuclear antigens are conserved, conformation-dependent and active site regions Clin Exp Rheumatol 1994 12: (Suppl.11) S27\u201331","journal-title":"Clin Exp Rheumatol"},{"key":"BF2401870_CR32","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1159\/000237385","volume":"111","author":"CA Castano","year":"1996","unstructured":"Castano CA, Tan EM . Recent developments in the understanding of antinuclear autoantibodies Int Arch Allergy Immunol 1996 111: 308\u2013313","journal-title":"Int Arch Allergy Immunol"},{"key":"BF2401870_CR33","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3109\/08916939409009531","volume":"18","author":"IP Yeo","year":"1994","unstructured":"Yeo IP, Toh BH . Cell cycle-associated autoantibodies: markers for autoimmunity and probes for molecular cell biology Autoimmunity 1994 18: 291\u2013300","journal-title":"Autoimmunity"},{"key":"BF2401870_CR34","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/sj.leu.2400519","volume":"11","author":"TD Golan","year":"1997","unstructured":"Golan TD . The nuclear compartment of living cells is not an absolute immunologically sequestered site: evidence for spontaneous intranuclear entry of lupus autoantibodies to living cells Leukemia 1997 11: 6\u20139","journal-title":"Leukemia"},{"key":"BF2401870_CR35","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/271067a0","volume":"271","author":"D Alarcon-Segovia","year":"1978","unstructured":"Alarcon-Segovia D, Ruiz Arguelles A, Fishbein E . Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors Nature 1978 271: 67\u201369","journal-title":"Nature"},{"key":"BF2401870_CR36","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/00002281-199709000-00003","volume":"9","author":"AR Cabral","year":"1997","unstructured":"Cabral AR, Alarcon-Segovia d . Autoantibodies in systemic lupus erythematosus Curr Opin Rheumatol 1997 9: 387\u2013392","journal-title":"Curr Opin Rheumatol"},{"key":"BF2401870_CR37","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1006\/jaut.1996.0038","volume":"9","author":"D Alarcon-Segovia","year":"1996","unstructured":"Alarcon-Segovia D, Llorente P, Ruiz Arguelles A . The penetration of autoantibodies into cells may induce tolerance to self by apoptosis of autoreactive lymphocytes and cause autoimune disease by dysregulation and\/or cell damage J Autoimmunity 1996 9: 295\u2013300","journal-title":"J Autoimmunity"},{"key":"BF2401870_CR38","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1182\/blood.V76.12.2462.2462","volume":"76","author":"H Kolb","year":"1990","unstructured":"Kolb H, Mittermuller J, Cleem C, Holler E, Ledderose G, Brehm G, Heim M, Wilmanns W . Donor leukocyute transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients Blood 1990 76: 2462\u20132466","journal-title":"Blood"},{"key":"BF2401870_CR39","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1056\/NEJM199401133300204","volume":"330","author":"D Porter","year":"1994","unstructured":"Porter D, Roth M, McGarigle C, Ferrara J, Antin J . Induction of graft versus host disease as immunotherapy for relapsed chronic myeloid leukemia New Engl J Med 1994 330: 100\u2013105","journal-title":"New Engl J Med"},{"key":"BF2401870_CR40","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/00001622-199603000-00004","volume":"8","author":"SA Giralt","year":"1996","unstructured":"Giralt SA, Kolb HJ . Donor lymphocyte infusions Curr Opin Oncol 1996 8: 96\u2013102","journal-title":"Curr Opin Oncol"},{"key":"BF2401870_CR41","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1073\/pnas.89.4.1468","volume":"89","author":"W Chen","year":"1992","unstructured":"Chen W, Peace D, Rovira D, You S, Cheever M . T cell immunity to the joining region of p210 BCR-ABL protein Proc Natl Acad Sci USA 1992 89: 1468\u20131473","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2401870_CR42","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1172\/JCI117473","volume":"94","author":"M Talpaz","year":"1994","unstructured":"Talpaz M, Estrov Z, Kantarjian H, Ku S, Foteh A, Kurzrock R . Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia: analysis by polymerase chain reaction of individual colonies J Clin Invest 1994 94: 1383\u20131389","journal-title":"J Clin Invest"},{"key":"BF2401870_CR43","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1172\/JCI119622","volume":"100","author":"KW Wucherpfennig","year":"1997","unstructured":"Wucherpfennig KW, Catz I, Hausmann S, Strominger JL, Steinman L, Warren KG . Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients: identity of key contact residues in the B-cell and T-cell epitopes J Clin Invest 1997 100: 1114\u20131122","journal-title":"J Clin Invest"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2401870.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2401870","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2401870.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:24:06Z","timestamp":1682036646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2401870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8,31]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2000,9,1]]}},"alternative-id":["BF2401870"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2401870","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,8,31]]},"assertion":[{"value":"7 February 2000","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2000","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}